BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Sciton Announces Collaboration With Michelson Diagnostics to Develop OCT Image-Guided Laser Applications

  “VivoSight OCT integrates well into our product portfolio,” remarks Dan Negus, President of Sciton.

  November 1, 2017

   · 

  3 min read
• Business

  Cantel Medical Announces 21% Increase in Semiannual Dividend

  Cantel Medical Corporation announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.07 to $0.085 per outstanding share of the Company’s Common Stock.

  November 1, 2017

   · 

  1 min read
• Drug Development

  Bexion Pharma Announces Initiation of Phase 1b Clinical Trial of BXQ-350 in Patients with Advanced Solid Tumors in Collaboration with CTI Clinical Trial and Consulting

  The company announced in September 2017 the successful completion of the First-in-Human Phase 1a trial, where four sites.

  November 1, 2017

   · 

  6 min read
• Business

  ChemoCentryx to Hold Third Quarter 2017 Financial Results Conference Call on Tuesday, November 7, 2017

  Management will host a conference call beginning at 5:00 p.m. ET to discuss these results and to answer questions.

  November 1, 2017

   · 

  2 min read
• Pharm Country

  Daxor Corporation Announces Share Buyback Program

  The Board of Directors of Daxor has voted to re-authorize the company’s share buyback for an amount of up to 300,000 shares for the next 12 months.

  November 1, 2017

   · 

  1 min read
• Business

  Skyline Medical Enters into Strategic Collaboration with Helomics to Develop Next Generation of Personalized Cancer Diagnostics

  The deal will use the Helomics D-CHIP platform to develop new approaches for personalized cancer diagnosis and care.

  November 1, 2017

   · 

  6 min read
• Business

  Catalyst Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9th, 2017

  Catalyst management will host a conference call at 8:30 a.m. EST to discuss the financial results and to provide a corporate update.

  November 1, 2017

   · 

  2 min read
• Drug Development

  Resverlogix Announces Fifth Positive Recommendation From Data Safety Monitoring Board for Phase III Study of Apabetalone

  A data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without any modification.

  November 1, 2017

   · 

  3 min read
• Drug Development

  AbbVie Announces Positive Phase III Extension Study Data for Investigational Oral Treatment Elagolix for Management of Endometriosis With Associated Pain

  In the extension studies, elagolix demonstrated sustained reduction in average monthly menstrual pelvic pain and non-menstrual pelvic pain in women through the 12-month treatment period.

  November 1, 2017

   · 

  10 min read
• Business

  iCAD to Report Third Quarter 2017 Financial Results on Wednesday, November 8

  The company will release financial results for the three and nine months ended September 30, 2017 after the close of the market.

  November 1, 2017

   · 

  3 min read